Ozempic vs Wegovy: Which Is Better for Weight Loss?

If you've been researching GLP-1 medications, you've almost certainly come across both Ozempic and Wegovy. They sound different, they're marketed differently, and they carry very different price tags depending on your insurance. But here's the twist most people don't realize until they dig in: they're actually the same active ingredient — semaglutide — just approved for different purposes and dispensed at different doses.

So when people ask "Ozempic vs Wegovy — which is better?", the real answer depends entirely on what you're trying to accomplish and what your doctor has prescribed. Let's break it all down clearly.

What Is Ozempic?

Ozempic (semaglutide) was approved by the FDA in 2017 for the treatment of type 2 diabetes. It's a once-weekly injectable medication that lowers blood sugar, reduces cardiovascular risk, and — as millions of people discovered — causes meaningful weight loss as a side effect. Ozempic comes in doses of 0.5 mg, 1 mg, and 2 mg per week.

Because weight loss wasn't its primary approval, Ozempic is technically prescribed off-label when a doctor uses it purely for obesity treatment. That said, off-label prescribing is completely legal and common in medicine.

What Is Wegovy?

Wegovy is also semaglutide — but it was specifically approved by the FDA in 2021 for chronic weight management in adults with obesity or overweight with at least one weight-related condition. The key difference is the maximum dose: Wegovy goes up to 2.4 mg per week, meaningfully higher than Ozempic's 2 mg ceiling.

Wegovy follows a structured titration schedule over 16–20 weeks, gradually increasing your dose to minimize nausea and other GI side effects before reaching the full 2.4 mg maintenance dose.

Key Differences at a Glance

• Active ingredient: Both are semaglutide
• FDA approval: Ozempic = type 2 diabetes; Wegovy = chronic weight management
• Max weekly dose: Ozempic 2 mg vs Wegovy 2.4 mg
• Pen device: Different delivery devices, not interchangeable
• Insurance coverage: Ozempic often covered for diabetes; Wegovy coverage varies widely
• List price: Both are in the $900–$1,400/month range without insurance

How Much Weight Can You Actually Lose?

This is what most people really want to know. The clinical trial data for semaglutide used in the STEP trials — which studied the Wegovy 2.4 mg dose — showed impressive results over 68 weeks.

That means someone starting at 220 lbs could expect to lose roughly 30 lbs on average. Some people lose significantly more — around 15–20% — and others lose less. Individual response varies based on diet, activity level, starting weight, and metabolic factors.

Since Ozempic tops out at 2 mg (lower than Wegovy's 2.4 mg), you'd generally expect slightly less weight loss with Ozempic compared to a full Wegovy course — though many people still see substantial results at the 1–2 mg doses.

But Wait — Is There Something Better Than Both?

Here's where the conversation in 2026 has evolved significantly. While Ozempic vs Wegovy is an important comparison, many patients and clinicians are now also asking about tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) — a newer dual GIP/GLP-1 receptor agonist.

The head-to-head data published from the SURMOUNT-5 trial in 2025 was striking:

Tirzepatide participants in the SURMOUNT trials lost an average of 20.2% of body weight — nearly 7 full percentage points more than semaglutide. For someone at 220 lbs, that's the difference between losing ~30 lbs and losing ~44 lbs.

That doesn't automatically make tirzepatide the right choice for everyone — side effect profiles, cost, insurance coverage, and individual tolerance all matter. But it's worth knowing the full landscape when you're making this decision.

So Which Is Better: Ozempic or Wegovy?

For weight loss specifically, Wegovy has the edge over Ozempic because:

• It's approved and studied at the higher 2.4 mg dose
• The titration schedule is optimized for weight management
• Insurance is more likely to cover it for obesity (though coverage is still inconsistent)
• Your doctor can prescribe it on-label, which simplifies prior authorization

For people with type 2 diabetes who also want weight loss benefits, Ozempic may be more appropriate — and is much more likely to be covered by insurance under your diabetes diagnosis.

What About Cost and Insurance?

Cost is one of the biggest practical factors in this decision. Here's the reality in 2026:

• Ozempic with diabetes diagnosis: Often covered well by Medicare Part D and commercial insurance
• Wegovy for obesity: Coverage has improved but remains inconsistent — many plans still exclude weight loss medications
• Manufacturer savings cards: Both Novo Nordisk programs can reduce out-of-pocket costs significantly for eligible patients
• Compounded semaglutide: Was available during shortage periods but FDA has tightened restrictions — verify current status with your provider

If cost is the primary concern, working with your doctor to determine which indication you qualify for — and which is most likely to be covered — is a smarter strategy than simply assuming one is cheaper than the other.

Questions to Ask Your Doctor

Walking into your appointment prepared can save you a lot of back-and-forth. Consider asking:

• Do I qualify for Wegovy on-label, or would Ozempic be prescribed off-label for my situation?
• Which is more likely to be covered under my specific insurance plan?
• Given my health history, am I a candidate for tirzepatide instead?
• What weight loss target is realistic for me based on my starting point?
• How will we know if the medication is working well enough to continue?

Use a Calculator to Set Realistic Expectations

One of the most useful things you can do before or after starting a GLP-1 medication is run the numbers for your specific situation. Average trial data is helpful context, but your projected weight loss depends on your starting weight, your goal, and which medication and dose you're on.

That's exactly what our free tool is built for. Try the GLP1Calc weight loss calculator to see a personalized estimate based on your starting weight and the medication you're considering — whether that's Ozempic, Wegovy, or tirzepatide.

The Bottom Line

Ozempic and Wegovy are the same molecule doing slightly different jobs at different doses. For pure weight loss outcomes, Wegovy's higher approved dose gives it an edge — but insurance coverage, your health history, and whether you have diabetes will often make the decision for you.

And if you're open to exploring all your options, tirzepatide's substantially stronger weight loss data in 2025 head-to-head trials means it's worth a serious conversation with your prescriber. The best GLP-1 for you is ultimately the one you can access, afford, tolerate, and stay consistent with over the long term.